Drugs / Povidine-iodine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06836271 | Mar → Apr 2025 overdue | prostate cancer | Hitit University | Not yet recruiting | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT03571100 Comparator | May 2018 → May 2019 | age-related macular degeneration, retinal vein occlusion | Mid Atlantic Retina | Unknown | No outcome recorded |
| Phase 2/3 | NCT03640507 Comparator | Oct 2018 → May 2019 | — | Columbia University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Povidine-iodine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03640507 ↗ |
| Modality | Other / unclassified | “povidone-iodine disinfection” PMID 42369177 ↗ Jun 2026 |
| Route | Topical | “Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.” NCT03640507 ↗ |